These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2864784)

  • 21. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
    Franco-Cereceda A; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
    Owen MP
    J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
    Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
    J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.
    Wahlestedt C; Yanaihara N; Håkanson R
    Regul Pept; 1986 Feb; 13(3-4):307-18. PubMed ID: 3010387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of neuropeptide Y on electrically induced contractions in the longitudinal and circular smooth muscle layers of the female rabbit urethra.
    Sjögren C; Andersson KE; Andersson PO; Mattiasson A; Uvelius B
    Acta Physiol Scand; 1988 Jun; 133(2):177-81. PubMed ID: 2852440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.
    Cox HM; Tough IR
    Br J Pharmacol; 2002 Mar; 135(6):1505-12. PubMed ID: 11906964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation.
    Nilsson T; You J; Sun X; Hedner T; Edvinsson L
    Blood Press; 1996 May; 5(3):164-9. PubMed ID: 8790927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nimodipine, Bay K 8644 and pinacidil on alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction in human hand veins.
    Arner M; Högestätt ED; Andersson KE
    Acta Physiol Scand; 1988 Jul; 133(3):417-22. PubMed ID: 2465670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presynaptic inhibitory effects of the peptides NPY, PYY and PP on nicotinic EPSPs in guinea-pig gastric myenteric neurones.
    Schemann M; Tamura K
    J Physiol; 1992; 451():79-89. PubMed ID: 1403832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat.
    Edvinsson L; Emson P; McCulloch J; Tatemoto K; Uddman R
    Neurosci Lett; 1983 Dec; 43(1):79-84. PubMed ID: 6689442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction.
    Vu HQ; Budai D; Duckles SP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):852-7. PubMed ID: 2600818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
    Ralevic V; Edvinsson L; Burnstock G
    Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenergic and non-adrenergic vasoconstrictor mechanisms in the human nasal mucosa.
    Fischer L; Auberson S; Bretton C; Lacroix JS
    Rhinology; 1993 Mar; 31(1):11-5. PubMed ID: 8100640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.
    Corder R; Lowry PJ; Withrington PG
    Br J Pharmacol; 1987 Apr; 90(4):785-90. PubMed ID: 3580708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
    Gradin KA; Li JY; Zhu H; Simonsen U
    Eur J Pharmacol; 2008 Dec; 601(1-3):118-23. PubMed ID: 18851959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV; Steiner M; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.